%0 Journal Article
%T Adipose-derived stem cells in diabetic foot care: Bridging clinical trials and practical application.
%A Tseng SL
%A Kang L
%A Li ZJ
%A Wang LQ
%A Li ZM
%A Li TH
%A Xiang JY
%A Huang JZ
%A Yu NZ
%A Long X
%J World J Diabetes
%V 15
%N 6
%D 2024 Jun 15
%M 38983804
%F 4.56
%R 10.4239/wjd.v15.i6.1162
%X Diabetic foot ulcers (DFUs) pose a critical medical challenge, significantly im-pairing the quality of life of patients. Adipose-derived stem cells (ADSCs) have been identified as a promising therapeutic approach for improving wound healing in DFUs. Despite extensive exploration of the mechanical aspects of ADSC therapy against DFU, its clinical applications remain elusive. In this review, we aimed to bridge this gap by evaluating the use and advancements of ADSCs in the clinical management of DFUs. The review begins with a discussion of the classification and clinical management of diabetic foot conditions. It then discusses the current landscape of clinical trials, focusing on their geographic distribution, reported efficacy, safety profiles, treatment timing, administration techniques, and dosing considerations. Finally, the review discusses the preclinical strategies to enhance ADSC efficacy. This review shows that many trials exhibit biases in study design, unclear inclusion criteria, and intervention protocols. In conclusion, this review underscores the potential of ADSCs in DFU treatment and emphasizes the critical need for further research and refinement of therapeutic approaches, with a focus on improving the quality of future clinical trials to enhance treatment outcomes and advance the field of diabetic wound care.